
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country
Nathalie Goutté, Philippe Sogni, Noelle Bendersky, et al.
Journal of Hepatology (2016) Vol. 66, Iss. 3, pp. 537-544
Open Access | Times Cited: 92
Nathalie Goutté, Philippe Sogni, Noelle Bendersky, et al.
Journal of Hepatology (2016) Vol. 66, Iss. 3, pp. 537-544
Open Access | Times Cited: 92
Showing 1-25 of 92 citing articles:
Global Epidemiology and Genetics of Hepatocellular Carcinoma
Ming Ren Toh, Evelyn Wong, Sunny H. Wong, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 766-782
Closed Access | Times Cited: 293
Ming Ren Toh, Evelyn Wong, Sunny H. Wong, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 766-782
Closed Access | Times Cited: 293
Hepatocellular carcinoma in the setting of alcohol-related liver disease
Nathalie Ganne‐Carrié, Pierre Nahon
Journal of Hepatology (2019) Vol. 70, Iss. 2, pp. 284-293
Open Access | Times Cited: 289
Nathalie Ganne‐Carrié, Pierre Nahon
Journal of Hepatology (2019) Vol. 70, Iss. 2, pp. 284-293
Open Access | Times Cited: 289
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Daniel Q. Huang, Philippe Mathurin, Helena Cortez‐Pinto, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 37-49
Open Access | Times Cited: 279
Daniel Q. Huang, Philippe Mathurin, Helena Cortez‐Pinto, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 37-49
Open Access | Times Cited: 279
Inequities in primary liver cancer in Europe: The state of play
Loreta A. Kondili, Jeffrey V. Lazarus, Peter Jepsen, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 4, pp. 645-660
Open Access | Times Cited: 21
Loreta A. Kondili, Jeffrey V. Lazarus, Peter Jepsen, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 4, pp. 645-660
Open Access | Times Cited: 21
Thermosensitive hydrogels for sustained-release of sorafenib and selenium nanoparticles for localized synergistic chemoradiotherapy
Lan Zheng, Chang'e Li, Xiaoting Huang, et al.
Biomaterials (2019) Vol. 216, pp. 119220-119220
Closed Access | Times Cited: 105
Lan Zheng, Chang'e Li, Xiaoting Huang, et al.
Biomaterials (2019) Vol. 216, pp. 119220-119220
Closed Access | Times Cited: 105
The Theory and Practice of Pancreatic Surgery in France
Olivier Farges, Noelle Bendersky, Stéphanie Truant, et al.
Annals of Surgery (2017) Vol. 266, Iss. 5, pp. 797-804
Closed Access | Times Cited: 104
Olivier Farges, Noelle Bendersky, Stéphanie Truant, et al.
Annals of Surgery (2017) Vol. 266, Iss. 5, pp. 797-804
Closed Access | Times Cited: 104
The oncologic burden of hepatitis C virus infection: A clinical perspective
Harrys A. Torres, Terri Lynn Shigle, Nassim Hammoudi, et al.
CA A Cancer Journal for Clinicians (2017) Vol. 67, Iss. 5, pp. 411-431
Open Access | Times Cited: 98
Harrys A. Torres, Terri Lynn Shigle, Nassim Hammoudi, et al.
CA A Cancer Journal for Clinicians (2017) Vol. 67, Iss. 5, pp. 411-431
Open Access | Times Cited: 98
Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020
Vincent Mallet, Nathanaël Beeker, Samir Bouam, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 4, pp. 848-855
Open Access | Times Cited: 66
Vincent Mallet, Nathanaël Beeker, Samir Bouam, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 4, pp. 848-855
Open Access | Times Cited: 66
Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1166-1166
Open Access | Times Cited: 23
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1166-1166
Open Access | Times Cited: 23
EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL
Mingang Pan, Muyu Luo, Lele Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 14
Mingang Pan, Muyu Luo, Lele Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 14
NELL2 suppresses epithelial-mesenchymal transition and induces ferroptosis via notch signaling pathway in HCC
Shiqi Liu, Haomin Wu, Pengjie Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Shiqi Liu, Haomin Wu, Pengjie Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study
Charlotte Costentin, Abbas Mourad, Pierre Lahmek, et al.
Cancer (2018) Vol. 124, Iss. 9, pp. 1964-1972
Open Access | Times Cited: 65
Charlotte Costentin, Abbas Mourad, Pierre Lahmek, et al.
Cancer (2018) Vol. 124, Iss. 9, pp. 1964-1972
Open Access | Times Cited: 65
The Epidemiology of Acute Liver Failure
Nina Weiler, Andreas Schlotmann, Andreas A. Schnitzbauer, et al.
Deutsches Ärzteblatt international (2020)
Open Access | Times Cited: 59
Nina Weiler, Andreas Schlotmann, Andreas A. Schnitzbauer, et al.
Deutsches Ärzteblatt international (2020)
Open Access | Times Cited: 59
Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus
Vincent Mallet, Lucia Parlati, Alessandro Martinino, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 2, pp. 265-274
Open Access | Times Cited: 44
Vincent Mallet, Lucia Parlati, Alessandro Martinino, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 2, pp. 265-274
Open Access | Times Cited: 44
Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness
Pegah Golabi, Isakov Va, Zobair M. Younossi
Clinics in Liver Disease (2023) Vol. 27, Iss. 2, pp. 173-186
Closed Access | Times Cited: 20
Pegah Golabi, Isakov Va, Zobair M. Younossi
Clinics in Liver Disease (2023) Vol. 27, Iss. 2, pp. 173-186
Closed Access | Times Cited: 20
Transarterial Radioembolization (TARE) Agents beyond 90Y-Microspheres
Christelle Bouvry, Xavier Palard, Julien Edeline, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-14
Open Access | Times Cited: 55
Christelle Bouvry, Xavier Palard, Julien Edeline, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-14
Open Access | Times Cited: 55
Hepatocellular carcinoma in Australia 1982‐2014: Increasing incidence and improving survival
M. Christopher Wallace, David B. Preen, Mark W. Short, et al.
Liver International (2018) Vol. 39, Iss. 3, pp. 522-530
Closed Access | Times Cited: 52
M. Christopher Wallace, David B. Preen, Mark W. Short, et al.
Liver International (2018) Vol. 39, Iss. 3, pp. 522-530
Closed Access | Times Cited: 52
Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases
Sumeet K. Asrani, Marwan Ghabril, Alexander Kuo, et al.
Hepatology (2021) Vol. 75, Iss. 5, pp. 1289-1299
Open Access | Times Cited: 36
Sumeet K. Asrani, Marwan Ghabril, Alexander Kuo, et al.
Hepatology (2021) Vol. 75, Iss. 5, pp. 1289-1299
Open Access | Times Cited: 36
Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?
Philippe Icard, Luca Simula, Zherui Wu, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100790-100790
Open Access | Times Cited: 36
Philippe Icard, Luca Simula, Zherui Wu, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100790-100790
Open Access | Times Cited: 36
Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022?
Clémence M. Canivet, Jérôme Boursier
Diagnostics (2022) Vol. 13, Iss. 1, pp. 91-91
Open Access | Times Cited: 25
Clémence M. Canivet, Jérôme Boursier
Diagnostics (2022) Vol. 13, Iss. 1, pp. 91-91
Open Access | Times Cited: 25
Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancer
Pierre Nahon, Maxime Ronot, Olivier Sutter, et al.
BMJ Open (2024) Vol. 14, Iss. 2, pp. e083701-e083701
Open Access | Times Cited: 4
Pierre Nahon, Maxime Ronot, Olivier Sutter, et al.
BMJ Open (2024) Vol. 14, Iss. 2, pp. e083701-e083701
Open Access | Times Cited: 4
Global, regional, and national burden of retinoblastoma in children aged under 10 years from 1990 to 2021 and projections for future disease burden
Hongjun Zhu, Meng Zhao, Jinxin Zheng
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Hongjun Zhu, Meng Zhao, Jinxin Zheng
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Reduced survival for rural patients with hepatocellular carcinoma within a tertiary hospital network: treatment equality is not enough
Andrew R. Chin, Ali Galalah Mostafa Ismail, Weijun Fan, et al.
Internal Medicine Journal (2025)
Closed Access
Andrew R. Chin, Ali Galalah Mostafa Ismail, Weijun Fan, et al.
Internal Medicine Journal (2025)
Closed Access
Machine learning-based integration reveals immunological heterogeneity and the clinical potential of T cell receptor (TCR) gene pattern in hepatocellular carcinoma
Zewei Zhuo, Huihuan Wu, Lingli Xu, et al.
APOPTOSIS (2025)
Closed Access
Zewei Zhuo, Huihuan Wu, Lingli Xu, et al.
APOPTOSIS (2025)
Closed Access
Differential Association of Hepatocellular Carcinoma Related to Hepatitis B Between Urban and Rural Areas in Africa Using Satellite Spatial Scaling Data
Erin Mann, Joseph Akambase, Kelly M. Searle, et al.
JCO Global Oncology (2025), Iss. 11
Open Access
Erin Mann, Joseph Akambase, Kelly M. Searle, et al.
JCO Global Oncology (2025), Iss. 11
Open Access